None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adult men and women aged 40 to 85 years old 2) Those who have been diagnosed with ischemic stroke or hemorrhagic stroke (including subarachnoid hemorrhage) and have completed acute treatment and have started or are able to begin rehabilitation treatment 3) A person who decides to participate voluntarily or through the will of a legal representative and signs a consent form
Exclusion criteria
Exclusion criteria: 1) Those with a history of malignant tumor within 5 years of the screening visit 2) People with gastrointestinal, endocrine, and cardiovascular diseases that cannot be controlled by diet or drug treatment 3) Persons with a seriously unstable medical condition (based on the judgment of the attending physician based on the results of clinical laboratory tests, vital signs, etc.) 4) Those who participated in another clinical trial within 1 month before the start of the study 5) Those who are not suitable for participation in this clinical trial according to the judgment of the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EQ-5D, EQ-VAS | — |
Secondary
| Measure | Time frame |
|---|---|
| daily living ability evaluation(K-BADL, S-IADL, K-MBI), CSEI-s, Blood failure scale;Economic evaluation;Safety evaluation(Adverse effect) | — |
Countries
Korea, Republic of
Contacts
Wonkwang University